CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it will be showcasing its new Cyto Study Manager solution at this year’s Society of Toxicology (“SOT”) meeting in Phoenix, Arizona March 24th -26th.
Supporting Genetic Toxicology investigations, the Cyto Study Manager integrates all comet and micronucleus data management processes into one simple, easy-to-use system that can be accessed securely from the laboratory and the office via an organization’s own internal network.
Data acquisition and scoring systems such as Comet Assay IV are fully integrated with the system, sending data directly to the Cyto Study Manager database. All reports can then be seamlessly generated from within the system and automatically combined into final study reports.
Live demonstrations of Cyto Study Manager will be offered throughout the SOT at Perceptive Instruments booth #924
“We've recently added a range of exciting new features to Cyto Study Manager,” commented Gary Kyle, Support and Development at Perceptive Instruments, “These features include fully customizable sample coding systems, simple-to-use historical data controls, and an experiment checklist which automatically guides users through the process of running their study.”
Perceptive Instruments (Perceptive), now operating as part of Instem, develops, manufactures and supplies image analysis and data processing solutions that are primarily focused on the areas of genetic toxicology, microbiology and immunology. Perceptive solutions are deployed in 49 countries at leading universities and research institutes and are supporting various government programs such as those at the National Center for Toxicological Research, a Food & Drug Administration division. Perceptive products also serve small and medium-sized companies along with many of today’s multinational organizations, including many of the leading global pharmaceutical companies.
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
To learn more about Instem solutions and its mission, please visit www.instem.com.
Meeting clients at the intersection of investment & return™.